Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 25 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Pharmaceutical / Industry				UCIRB #14735B GV-001.010 (TNF-ELF), NCT00496236

Last Modified: 10/21/2008 First Published: 6/23/2003


2.		Phase II Randomized Study of Fruit and Vegetable Extracts in Patients With Stage I-IVB Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				CCCWFU-0112 CCCWFU-60A02, CCCWFU-BG03-161, NCT00064298


3.		Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06U.195 NCT00358007

First Published: 3/22/2007


4.		Phase II Study of Photodynamic Therapy With Porfimer Sodium in Patients With Pre-Malignant or Malignant Lesions or Condemned Mucosa Syndrome in the Upper Aerodigestive Tract

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				SCCC-2002103 SCCC-02/618C, SCCC-20050715, SCCC-20020618, NCT00453336


5.		Sorafenib Plus Carboplatin and Paclitaxel in Head and Neck Squamous Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				2006-0940 NCT00494182


6.		UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				19 and over				Other				F070824015 UAB 0718, NCT00570232


7.		Phase II Trial Evaluating Elimination of Radiation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				07-0142 NCT00593840


8.		Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				08-050 NCT00713219


9.		A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Other				05C.255 NCT00329589

Last Modified: 11/30/2006 First Published: 11/22/2006


10.		Phase I Randomized Pilot Study of Adjuvant Mutant p53 Peptide-Pulsed Dendritic Cell Vaccine With or Without T-Helper Peptides in Patients With Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				Over 18				NCI				PCI-03-156 PCI-0507062, NCT00404339

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute